Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:11 AM
Ignite Modification Date:
2025-12-25 @ 1:11 AM
NCT ID:
NCT04268693
Eligibility Criteria:
Inclusion Criteria:
* diagnosis of stage I - III triple negative breast cancer
* scheduled to receive a neoadjuvant chemotherapy regimen including doxorubicin
* receiving treatment at the George Washington University Cancer Center
Exclusion Criteria:
* diagnosis of other types of breast cancer
* not scheduled to receive doxorubicin as part of the neoadjuvant chemotherapy regimen
* not planning to receive neoadjuvant chemotherapy at the George Washington University Cancer Center
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
21 Years
Study:
NCT04268693
Study Brief:
Protocol Section:
NCT04268693